Preserved in Portico This version is not peer-reviewed
Cell Fusion as a Link between the SARS-CoV-2 Spike Protein, COVID-19 Complications, and Vaccine Side Effects
: Received: 2 June 2021 / Approved: 4 June 2021 / Online: 4 June 2021 (08:21:00 CEST)
: Received: 7 September 2021 / Approved: 9 September 2021 / Online: 9 September 2021 (10:54:14 CEST)
A peer-reviewed article of this Preprint also exists.
Journal reference: Oncotarget 2021
A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus producing syncytia found in COVID-19 patients. This commentary proposes how this ability enables spike to cause COVID-19 complications as well as side effects of COVID-19 vaccines, and suggests how these effects can be prevented..
cell fusion; syncytia; cell hybrids; viruses; coronaviruses; SARS-CoV-2; COVID-19; fusogens; blood coagulation cascade; thrombosis, cancer; vaccines; neurological complications
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.